RECOGNIZING FEBRUARY 3 AS TOPICAL STEROID WITHDRAWAL SYNDROME AWARENESS DAY.
HR 174 designates February 3 as Topical Steroid Withdrawal Syndrome Awareness Day, aiming to educate the public and support those affected by this condition.
HR 174 designates February 3 as Topical Steroid Withdrawal Syndrome Awareness Day, aiming to educate the public and support those affected by this condition.
HR 174 is a resolution aimed at designating February 3 as Topical Steroid Withdrawal Syndrome Awareness Day. The primary intent of this bill is to raise awareness about Topical Steroid Withdrawal Syndrome (TSWS), a condition that can occur in individuals who have used topical corticosteroids for extended periods. By establishing a specific day for awareness, the resolution seeks to educate the public, healthcare professionals, and policymakers about the challenges faced by those affected by TSWS.
HR 174 represents a significant step towards increasing awareness of Topical Steroid Withdrawal Syndrome by designating February 3 as a day of recognition. Through education and advocacy, the resolution aims to improve the understanding and support for those affected by this condition, ultimately contributing to better health outcomes and quality of life for individuals dealing with TSWS.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.